drugset / Trial / NCT02477072
Optimized Heparin Regimen in Vascular Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
Hypothesis: Optimal anticoagulation defined as an Activated Clotting Time (ACT) of 300 to 350 seconds obtained by weight-adjusted doses of unfractionated heparin (UFH) will improve the hemostatic environment downstream from the vascular clamp, provide better blood flow in the distal bed following peripheral revascularization surgery. Objectives: This study is designed to assess the effects of an optimized regimen of UFH on the hemostatic environment downstream from the vascular clamp in major vascular surgery.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-01
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Heparin | Other / unclassified | 100 iu/kg | Intravenous |
| Subject | Heparin | Other / unclassified | 5000 iu | Intravenous |